Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruixi Wang

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Annals of Medicine|October 22, 2025
Pan-immune-inflammation value predicts survival of patients with oesophageal squamous cell carcinoma receiving immunotherapy and chemoradiotherapy: a pooled analysis of two phase II trialsXingyuan Cheng, Kongjia Luo, Yilu Gao, et al.
Eclinicalmedicine|September 16, 2024
Long-term survival and post-hoc analysis of toripalimab plus definitive chemoradiotherapy for oesophageal squamous cell carcinoma: insights from the EC-CRT-001 phase II trialRuixi Wang, Yihong Ling, Baoqing Chen, et al.
Frontiers in Veterinary Science|April 22, 2025
Cloning, bioinformatics analysis, and expression of the ubiquitin 2 (ubq-2) gene from the dog roundworm <i>Toxocara canis</i>Pengchen Zhu, Xin Hu, Jiali Huang, et al.
Cardiovascular Diagnosis and Therapy|May 10, 2021
The significance of an integrated management mode of prenatal diagnosis-postnatal treatment for critical congenital heart disease in newbornsXiaohui Zhang, Shaoru He, Yumei Liu, et al.
The Oncologist|November 25, 2024
Induction chemotherapy plus chemoradiotherapy in esophageal cancer: long-term results and exploratory analyses of a randomized controlled trialShiliang Liu, Baoqing Chen, Yujia Zhu, et al.
Nature Communications|March 1, 2024
Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimabBaoqing Chen, Shiliang Liu, Yujia Zhu, et al.
Medicine|February 3, 2018
Treatment of Bacillus cereus endophthalmitis with endoscopy-assisted vitrectomyQintuo Pan, Yanhua Liu, Ruixi Wang, et al.
ACS Nano|May 20, 2026
Asymmetrically Coordinated Cu Single-Atom Nanozyme to Accelerate Inflammation and Immune Homeostasis Modulation in Acute Myocardial InfarctionYunchai Lin, Wenxian Chen, Xuan Zheng, et al.
Journal for Immunotherapy of Cancer|January 12, 2026
Serum cytokines predict response and survival in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD-1 antibody: analyses of two phase II clinical trialsBaoQing Chen, Junying Chen, Sifen Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2024
Comparison of Efficacy and Safety of Combined Chemoimmunotherapy With or Without Radiation Therapy for Stage IVB Esophageal Squamous Cell Carcinoma: A Multicenter Propensity Score Matching AnalysisBiqi Chen, Wenyan Chen, Qi Cheng, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Annals of Medicine|October 22, 2025
Pan-immune-inflammation value predicts survival of patients with oesophageal squamous cell carcinoma receiving immunotherapy and chemoradiotherapy: a pooled analysis of two phase II trialsXingyuan Cheng, Kongjia Luo, Yilu Gao, et al.
Eclinicalmedicine|September 16, 2024
Long-term survival and post-hoc analysis of toripalimab plus definitive chemoradiotherapy for oesophageal squamous cell carcinoma: insights from the EC-CRT-001 phase II trialRuixi Wang, Yihong Ling, Baoqing Chen, et al.
Frontiers in Veterinary Science|April 22, 2025
Cloning, bioinformatics analysis, and expression of the ubiquitin 2 (ubq-2) gene from the dog roundworm <i>Toxocara canis</i>Pengchen Zhu, Xin Hu, Jiali Huang, et al.
Cardiovascular Diagnosis and Therapy|May 10, 2021
The significance of an integrated management mode of prenatal diagnosis-postnatal treatment for critical congenital heart disease in newbornsXiaohui Zhang, Shaoru He, Yumei Liu, et al.
The Oncologist|November 25, 2024
Induction chemotherapy plus chemoradiotherapy in esophageal cancer: long-term results and exploratory analyses of a randomized controlled trialShiliang Liu, Baoqing Chen, Yujia Zhu, et al.
Nature Communications|March 1, 2024
Predictive role of ctDNA in esophageal squamous cell carcinoma receiving definitive chemoradiotherapy combined with toripalimabBaoqing Chen, Shiliang Liu, Yujia Zhu, et al.
Medicine|February 3, 2018
Treatment of Bacillus cereus endophthalmitis with endoscopy-assisted vitrectomyQintuo Pan, Yanhua Liu, Ruixi Wang, et al.
ACS Nano|May 20, 2026
Asymmetrically Coordinated Cu Single-Atom Nanozyme to Accelerate Inflammation and Immune Homeostasis Modulation in Acute Myocardial InfarctionYunchai Lin, Wenxian Chen, Xuan Zheng, et al.
Journal for Immunotherapy of Cancer|January 12, 2026
Serum cytokines predict response and survival in esophageal squamous cell carcinoma receiving chemoradiotherapy combined with anti-PD-1 antibody: analyses of two phase II clinical trialsBaoQing Chen, Junying Chen, Sifen Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 27, 2024
Comparison of Efficacy and Safety of Combined Chemoimmunotherapy With or Without Radiation Therapy for Stage IVB Esophageal Squamous Cell Carcinoma: A Multicenter Propensity Score Matching AnalysisBiqi Chen, Wenyan Chen, Qi Cheng, et al.
Pageof 4